Ownership Summary
A total of 10 institutions have reported a stake in Healthcare Triangle, Inc. (NASDAQ:HCTI) as of December 2025, according to recent 13F filings with the SEC.
- These investors collectively held 19328.6% of the company's total shares outstanding in December 2025, up from 16632.5% in September 2025.
- The company experienced a 23.29% quarterly change in institutional shares held, alongside an increase of 25.00% in total owners annually.
- Among the 10 institutional holders of Healthcare Triangle, 7 added to their stakes while 1 trimmed their positions and 2 held steady.
- Collectively, institutional investors increased their stake in Healthcare Triangle to 202.37K shares as of December 2025, a change that is up by 38.23K shares quarter on quarter and up 150.09K shares year over year.
- VANGUARD GROUP INC's holding of 80.43K shares as of December 31, 2025 makes it the primary institutional investor in Healthcare Triangle, owning 7681.57% of the stock.
- Among the most significant buyers of Healthcare Triangle during December 2025 were GEODE CAPITAL MANAGEMENT, LLC (12.66K), Scientech Research LLC (10.47K), CITIGROUP INC (10.01K), STATE STREET CORP (8.80K), Tower Research Capital LLC (TRC) (1.92K).
- Leading sellers of Healthcare Triangle stock in December 2025 included UBS Group AG (6.04K).
- The top 10 institutional holders of Healthcare Triangle for the quarter ending December 2025 included VANGUARD GROUP INC (80.43K), GEODE CAPITAL MANAGEMENT, LLC (53.79K), STATE STREET CORP (37.50K), Scientech Research LLC (10.47K), CITIGROUP INC (10.14K), UBS Group AG (7.62K), Tower Research Capital LLC (TRC) (1.92K), BNP PARIBAS FINANCIAL MARKETS (400), BANK OF AMERICA CORP /DE/ (54), MORGAN STANLEY (40).